Sophia Rein on HIV treatment with INSTIs and cardiovascular events

from The Lancet HIV in conversation with · host The Lancet Group

Peter Hayward is joined by Sophia Rein of the Harvard T H Chan School of Public Health to discuss an emulation of target trials using cohort data to look at risk of cardiovascular events in people taking INSTIs for HIV. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

Episode metadata supplied by the publisher feed · Published Nov 1, 2023

Embed this episode

Attribution link and audio player

Ready to play

Sophia Rein on HIV treatment with INSTIs and cardiovascular events

0:00 15:15

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Lancet HIV in conversation with?

This episode is 15 minutes long.

When was this The Lancet HIV in conversation with episode published?

This episode was published on November 1, 2023.

Can I download this The Lancet HIV in conversation with episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!